Anika Therapeutics, Inc. (ANIK) Gross profit 2016–2025
Anika Therapeutics, Inc. (ANIK) annual gross profit history from SEC filings — each fiscal year as reported.
$63.8MFY2025 · since FY2016: $79.4M → $63.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $63.8M | -16.0% |
| FY2024 | $76.0M | -7.9% |
| FY2023 | $82.5M | +12.7% |
| FY2022 | $73.2M | -11.7% |
| FY2021 | $82.9M | +20.2% |
| FY2020 | $69.0M | -19.6% |
| FY2019 | $85.9M | +15.6% |
| FY2018 | $74.3M | -13.7% |
| FY2017 | $86.1M | +8.4% |
| FY2016 | $79.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIK financial trends
ANIK RevenueANIK Net incomeANIK Net marginANIK Gross marginANIK Operating incomeANIK Operating marginANIK Operating cash flowANIK Free cash flowANIK Capital expendituresANIK Return on equityANIK Stock buybacksANIK Dividends paidANIK Total assetsANIK Total liabilitiesANIK Shareholders’ equityANIK overview →